GABRIELA KOHN: Open Payments
NPI 1891421715 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 14 payments from 14 companies in 2025. Trend: 2023 $35 · 2024 $297 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 1 | $120 |
| Octapharma USA, Inc. | 1 | $48 |
| TerSera Therapeutics LLC | 1 | $36 |
| ARRAY BIOPHARMA INC | 1 | $35 |
| Coherus Oncology, Inc. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Stemline Therapeutics Inc. | 1 | $30 |
| Aveo Pharmaceuticals, Inc. | 1 | $30 |
| Celgene Corporation | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $26 |
Products named: LORBRENA, PANZYGA, Zoladex, XALKORI, LOQTORZI, LYNPARZA, Orserdu, FOTIVDA.
Industry payments across CA — which companies pay providers there.
